This completely nullifies its bacteriostatic properties
Although rare (3.07/million), lipodystrophy is likely underdiagnosed [196]
METAOD004: A Phase IIa (double-blind, placebo-controlled, dose escalation) safety study with multiple daily doses (9, 27 or 54 mg AOD9604) administered orally (capsules) for seven days in 36 healthy clinically obese males presenting with a BMI 30 kg/m 2
Patients must know these potential reactions and seek medical assistance if severe symptoms occur
When traveling, the medication should be transported in an insulated container with ice packs if refrigeration will not be available, taking care to prevent direct contact between the medication and ice to avoid freezing
Be cautious with dosage, especially when combining multiple peptides, due to unknown interactions